Clemex Discloses First Quarter Results for FY 2009

    (Sales increase by 37% and $75 000 of Net Profit)

    Symbol: CXG.A-CDNX
    Shares Outstanding:  20,843,810

    MONTREAL, Sept. 18 /CNW Telbec/ - Clemex Technologies Inc. (TSX Venture
CXG.a), designer and manufacturer of Image Analysis systems and software for
microscopy applications, announced today its quarterly results for its first
quarter of FY2009 ending July 31 2008. For this first Quarter of FY 2009,
sales reached $1,519,682., an increase of $414,408 or 37% over last year for
the same period. The Corporation ends this Quarter with Net Earnings of
$75,533 while a $138,779. loss had been posted for Q1 last year. Earnings for
this Quarter were slightly affected by a non recurrent increase in
administrative expenses and professional fees related to the Company value
enhance process. Gross Margin for this First Quarter was 60%, down from 64%
for the same period last year. During this First Quarter, the Company made
important sales to strategic clients in diversified market segments such as
Universities (McMaster University, Hamilton ON, University of Toronto, Toronto
ON, Southwest University, El Paso TX), Metallurgical industries (OVAKO,
Hillfor Sweden, Nucor Strip, Arkansas) and finally to Pharmaceutical and Life
Sciences clients (PPDI, Milwaukee WI, Great Lake Brine Shrimps, Salt Lake
City, Utah).


    	                                                         First Quarter
                           Fiscal Year                      2009        2008
                                                               $           $
    Sales                                              1,519,682   1,105,274
    Cost of Sales                                        611,065     390,816
    Gross Margin                                         908,617     714,458

    Operating Expenses
      Commercial Expenses                                390,514     400,938
      Administrative Expenses                            242,901     217,051
      R&D less Tax credits                               144,976     134,682
      Amortization                                        19,791      25,719
      Interest & bank charges                             31,546      30,983
    Net foreign exchange loss                              3,356      43,864
                                                         833,085     853,237

    Net earnings                                          75,533    (138,779)

    Net earnings/lost per share                            0.004      (0.007)

    Clement Forget, President and CEO of Clemex Technologies declared: "Q1
results for FY2009 are encouraging and are in line with the Company strategic
forecasts. Our Sales efforts have allowed us to further develop our key
markets such as metallurgy and pharmaceuticals." He continued; "Our sales
performance in North America and abroad combined with the regain of the US $
let us anticipate more positive Quarters to come this year."

    About Clemex Technologies, Inc.

    Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research microscopy
laboratories. Clemex's customer base spans over many countries in America,
Europe, Asia and encompasses major Research and Development Centers,
prestigious Universities and large manufacturing industries in various fields
including automotive, aerospace, raw materials manufacturing, pharmaceuticals,
mining and other sectors.

    The CDNX has not reviewed and does not accept responsibility for the
    adequacy and accuracy of this news release.

For further information:

For further information: Clément Forget, Clemex Technologies Inc., (450)

Organization Profile

Clemex Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890